For endometrial cancer, Tang et al. observed elevated miR-106a level in cell lines (HEC-1-A, HEC-1B, RL95-2, AN3CA, Ishikawa, and JEC), which promotes tumor growth by targeting BCL2L11 [37]. Here, BCL2L11 is linked to endometrial cancer.